Regeneron (REGN) Tops Q4 EPS by 1c

Go back to Regeneron (REGN) Tops Q4 EPS by 1c

Regeneron Reports Fourth Quarter and Full Year 2016 Financial and Operating Results

February 9, 2017 6:30 AM EST

TARRYTOWN, N.Y., Feb. 9, 2017 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for the fourth quarter and full year 2016 and provided a business update.

Financial Highlights

($ in millions, except per share data)

Three... More